20:52 IST
NSE
Results Update
Astec Lifesciences Results Update
Astec LifeSciences announced its Q1 FY27 financial results, reporting total income of ₹84.3 crore and an EBITDA of ₹0.1 crore.
Astec Lifesciences Ltd
- Share price
- ₹748.20
- Market cap
- ₹1,667 Cr
- Revenue (annual)
- ₹448.1 Cr
- Net profit (annual)
- ₹-80.92 Cr
- P/E (TTM)
- -25.0×Sector 36.8×
- Promoter holding
- 71.96%-0.01% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Debt & Borrowing 12Price Movement Clarification 5Annual General Meeting 5Other Announcement 4Financial Results 4Employee Stock Options 4Board Meeting Outcome 4Management Change 3Results Update 2Fund Raise 1Board Meeting Date 1Annual Report 1
Time
2 announcements with these filters
20:18 IST
BSE
Results Update
Astec Lifesciences Results Update
Astec LifeSciences reported a 17.1% year-on-year increase in FY26 consolidated total income to ₹453.2 Crore. Despite a loss after tax of ₹80.9 Crore, the company achieved EBITDA breakeven at ₹0.5 Crore. Growth was primarily driven by improved volumes in the Enterprise and CDMO segments.
- Value
- ₹453.2 Cr